XORTX Therapeutics Inc. (XRTX.V)

CAD 1.62

(-7.43%)

Total Assets Summary of XORTX Therapeutics Inc.

  • XORTX Therapeutics Inc.'s latest annual total assets in 2023 was 7.21 Million CAD , down -41.59% from previous year.
  • XORTX Therapeutics Inc.'s latest quarterly total assets in 2024 Q2 was 4.79 Million USD , down -20.68% from previous quarter.
  • XORTX Therapeutics Inc. reported annual total assets of 12.34 Million CAD in 2022, down -28.58% from previous year.
  • XORTX Therapeutics Inc. reported annual total assets of 17.28 Million CAD in 2021, up 654.56% from previous year.
  • XORTX Therapeutics Inc. reported quarterly total assets of 4.79 Million USD for 2024 Q2, down -20.68% from previous quarter.
  • XORTX Therapeutics Inc. reported quarterly total assets of 5.46 Million USD for 2023 Q4, down -17.65% from previous quarter.

Annual Total Assets Chart of XORTX Therapeutics Inc. (2023 - 2014)

Historical Annual Total Assets of XORTX Therapeutics Inc. (2023 - 2014)

Year Total Assets Total Assets Growth
2023 7.21 Million CAD -41.59%
2022 12.34 Million CAD -28.58%
2021 17.28 Million CAD 654.56%
2020 2.29 Million CAD 110.52%
2019 1.08 Million CAD -14.01%
2018 1.26 Million CAD 157.9%
2017 490.6 Thousand CAD 73.69%
2016 282.46 Thousand CAD 0.0%
2014 180.08 Thousand CAD 0.0%

Peer Total Assets Comparison of XORTX Therapeutics Inc.

Name Total Assets Total Assets Difference
Arch Biopartners Inc. 1.17 Million CAD -515.628%
Covalon Technologies Ltd. 24.9 Million CAD 71.045%
Hemostemix Inc. 313.76 Thousand CAD -2197.916%
Universal Ibogaine Inc. 6.31 Million CAD -14.126%
Kane Biotech Inc. 5.68 Million CAD -26.917%
MedMira Inc. 3.65 Million CAD -97.438%
Marvel Biosciences Corp. 672.38 Thousand CAD -972.304%
NervGen Pharma Corp. 13.23 Million CAD 45.527%